Advocacy letters are one way METAvivor works to ensure the needs of people living with metastatic breast cancer are represented in policy decisions that affect research, access to care, clinical trials, and cancer data.
By joining with other patient advocacy, research, and healthcare organizations, METAvivor can help bring the MBC perspective directly to policymakers and decision-makers. Here are several recent advocacy efforts and why they matter to the metastatic breast cancer community.
Below are recent advocacy letters and policy efforts that METAvivor has supported or contributed to on behalf of the metastatic breast cancer community.
More advocacy letters and updates coming soon.
AD HOC Group for Medical Research OMB Proposed rule letter (7/10/26)
Access the full letter
VRBPAC Comment Letter (5/28/26)
Access the full letter
OVAC Letter of concern about slow grant dispersal (5/19/26)
Access the full letter
OVAC letter outlining FY 27 Funding requests (3/22/26)
Access the full letter
Defense Health Research Consortium Group letters to House and Senate supporting CDMRP Program Funding (3/13/2026)
Access the full letter on Defense Health Research Programs FY27 – Senate
Access the full letter on Defense Health Research Programs FY27 – House
Access the full letter on 2026 Defense Health Research Military Relevance
METAvivor only BCRP Funding Request letter (3/13/2026)
Access the full letter